1. A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral Therapy. (21st December 2020) Authors: McMahon, Deborah K; Zheng, Lu; Cyktor, Joshua C; Aga, Evgenia; Macatangay, Bernard J; Godfrey, Catherine; Para, Michael; Mitsuyasu, Ronald T; Hesselgesser, Joseph; Dragavon, Joan; Dobrowolski, Curtis; Karn, Jonathan; Acosta, Edward P; Gandhi, Rajesh T; Mellors, John W Journal: Journal of infectious diseases Issue: Volume 224:Number 4(2021) Page Start: 648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized Trial. (21st December 2017) Authors: Taiwo, Babafemi O; Marconi, Vincent C; Berzins, Baiba; Moser, Carlee B; Nyaku, Amesika N; Fichtenbaum, Carl J; Benson, Constance A; Wilkin, Timothy; Koletar, Susan L; Colasanti, Jonathan; Acosta, Edward P; Li, Jonathan Z; Sax, Paul E Journal: Clinical infectious diseases Issue: Volume 66:Number 11(2018) Page Start: 1794 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Implications of Efavirenz Pharmacogenetics When Switching From Efavirenz- to Dolutegravir-containing Antiretroviral Regimens. (15th July 2020) Authors: Haas, David W; Acosta, Edward P Journal: Clinical infectious diseases Issue: Volume 72:Number 10(2021) Page Start: 1820 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study. (5th April 2019) Authors: Viani, Rolando M; Ruel, Theodore; Alvero, Carmelita; Fenton, Terry; Acosta, Edward P; Hazra, Rohan; Townley, Ellen; Palumbo, Paul; Buchanan, Ann M; Vavro, Cindy; Singh, Rajendra; Graham, Bobbie; Anthony, Patricia; George, Kathleen; Wiznia, Andrew Journal: Journal of the Pediatric Infectious Diseases Society Issue: Volume 9:Number 2(2020) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis. (25th May 2020) Authors: Krogstad, Paul; Samson, Pearl; Acosta, Edward P; Moye, Jack; Townley, Ellen; Bradford, Sarah; Brown, Emily; Denson, Kayla; Graham, Bobbie; Hovind, Laura; Sise, Thucuma; Teppler, Hedy; Mathiba, Sisinyana Ruth; Fairlie, Lee; Winckler, Jana L; Slade, Gretchen; Meyers, Tammy Journal: Journal of the Pediatric Infectious Diseases Society Issue: Volume 10:Number 2(2021) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial. Issue 5 (May 2022) Authors: Ruel, Theodore D; Acosta, Edward P; Liu, Jessica P; Gray, Kathryn P; George, Kathleen; Montañez, Nicole; Popson, Stephanie; Buchanan, Ann M; Bartlett, Mattie; Dayton, Dale; Anthony, Patricia; Brothers, Cynthia; Vavro, Cynthia; Singh, Rajendra; Koech, Lucy; Vhembo, Tichaona; Mmbaga, Blandina T; Pi... Journal: Lancet Issue: Volume 9:Issue 5(2022) Page Start: e332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pilot evaluation of ivacaftor for chronic bronchitis. Issue 6 (June 2016) Authors: Solomon, George M; Hathorne, Heather; Liu, Bo; Raju, S Vamsee; Reeves, Ginger; Acosta, Edward P; Dransfield, Mark T; Rowe, Steven M Journal: Lancet Issue: Volume 4:Issue 6(2016) Page Start: e32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. (6th August 2018) Authors: Namazi, Golnaz; Fajnzylber, Jesse M; Aga, Evgenia; Bosch, Ronald J; Acosta, Edward P; Sharaf, Radwa; Hartogensis, Wendy; Jacobson, Jeffrey M; Connick, Elizabeth; Volberding, Paul; Skiest, Daniel; Margolis, David; Sneller, Michael C; Little, Susan J; Gianella, Sara; Smith, Davey M; Kuritzkes, Dani... Journal: Journal of infectious diseases Issue: Volume 218:Number 12(2018) Page Start: 1954 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗